JAN 07, 2020 8:42 AM PST

Kiss and tell: new test for kissing bug disease

WRITTEN BY: Tara Fernandez

Here’s one Latin lover that you do not want to get kissed by: the triatomine, or “kissing bug”. Known locally as pitos or chipos, these insects get their name for their penchant for biting people’s faces as they sleep at night. One seemingly harmless little “peck” can result in a potentially life-threatening illness known as Chagas disease, caused by the transmission of a protozoan parasite known as Trypansosoma cruzi, as illustrated in the video below.

 

 

There are more than 6 million people worldwide with Chagas disease, most of whom reside in Latin American countries. In these rural endemic regions, the lack of access to fully-equipped diagnostic laboratories makes positively identifying and treating Chagas disease particularly challenging.

In the acute phase of the disease, localized swelling at the site of the bite occurs, which can be accompanied by fevers, difficulty breathing and chest pain. If treated with the antiparasitic medication benznidazole during this early phase, the treatment is extremely effective in killing the parasites. However, if left undiagnosed and untreated, T. cruzi can go on to reside in the heart and digestive muscles, where it can wreak havoc, causing heart failure, neurological conditions and enlargement of the colon. At this advanced stage, Chagas disease medications are deemed useless and more costly therapeutics such as pacemakers and anticoagulants are required to manage the illness.

A recent field study conducted in the Gran Chaco region of Bolivia evaluated the potential of a rapid diagnostic test for establishing the presence of T. cruzi infections and has reported promising results in the journal PLOS Neglected Tropical Diseases

Commercially-available Chagas diagnostics include serological tests, blood smears and polymerase chain reactions -- all of which require patient blood samples, temperature-controlled reagents, specialized biochemistry lab equipment and trained technologists to interpret results. These are simply impractical for widespread application outside of urban centers. 

In contrast, the rapid diagnostic method being tested can be performed easily without specialist training, does not require refrigeration, provides diagnostic answers quickly and can work with just a few drops of blood from a finger prick.

Blood samples were collected from almost 700 Bolivian participants by researchers in mobile units, with the objective of testing this rapid diagnostic protocol against commercially-available gold standards. On a positive note, the rapid diagnostic system had a 97% capacity to detect infections, with a specificity (or ability to detect negative samples) of 96.1% - performing almost identically to the commercial tests run in a reference laboratory.

Besides being bitten by vectors, the parasite can also be transmitted by consumption of contaminated food, blood transfusions from infected donors, and from mother to child. Despite efforts to control vector infestation by spraying residential areas with insecticides and promoting the use of insect nets around beds to protect individuals from bites, Chagas disease continues to be rampant in some Latin American communities.

Unsurprisingly, the rapid diagnostic evaluation revealed that 44% of Bolivian individuals tested during the study were positive for T. cruzi.

The World Health Organization has made several big pushes to reduce Chagas disease transmission and promote awareness in Latin American countries since the 1990s, which has led to a dramatic reduction in the number of reported cases. Coupled with low-cost and easily accessible diagnostic tools such as those tested here, people in affected areas stand a much higher chance of resisting the disease.

 

Sources: EurekAlert!, World Health Organization.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
JAN 22, 2020
Clinical & Molecular DX
JAN 22, 2020
Biosignatures detect TB infections months before symptoms appear
What if there was a test that could detect tuberculosis six months before symptoms appear? Researchers at the University ...
FEB 21, 2020
Clinical & Molecular DX
FEB 21, 2020
Diagnosing COVID-19
Diagnosing coronavirus is done through next-generation sequencing, real-time RT-PCR tests, cell culture, and electron mi ...
MAR 23, 2020
Microbiology
MAR 23, 2020
The Loss of a Sense of Smell May be a Major Symptom of COVID-19
The loss of the sense of smell may be a symptom of a COVID-19 infection in people with no other symptoms.
APR 23, 2020
Clinical & Molecular DX
APR 23, 2020
FDA Approves At-Home Sample Collection Diagnostic Test for COVID-19
The coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). M ...
MAY 28, 2020
Clinical & Molecular DX
MAY 28, 2020
Pitcher Plants Inspire Kidney Stone Diagnostic
  Urine contains an abundance of dissolved salts and minerals such as calcium and uric acid. These can form crystal ...
JUN 30, 2020
Cardiology
JUN 30, 2020
Investigating How Aging Affects Cardiac Health in Marmosets
Age is something that scientists still struggle to understand. It seems to be built into the DNA and affects the human b ...
Loading Comments...